Works matching DE "BELATACEPT"
Results: 138
Tissue talks: immunophenotype of cells infiltrating the graft explains histological findings and the benefits of belatacept at 10 years.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 197, n. 2, p. 250, doi. 10.1111/cei.13296
- By:
- Publication type:
- Article
No augmentation of indoleamine 2,3‐dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients.
- Published in:
- Clinical & Experimental Immunology, 2018, v. 192, n. 2, p. 233, doi. 10.1111/cei.13093
- By:
- Publication type:
- Article
Mesenchymal stem cells control alloreactive CD8<sup>+</sup> CD28<sup>−</sup> T cells.
- Published in:
- Clinical & Experimental Immunology, 2013, v. 174, n. 3, p. 449, doi. 10.1111/cei.12199
- By:
- Publication type:
- Article
Belatacept in the treatment of acute T‐cell mediated rejection and maintenance immunosuppression in a paediatric kidney transplant recipient.
- Published in:
- Nephrology, 2022, v. 27, n. 7, p. 641, doi. 10.1111/nep.14036
- By:
- Publication type:
- Article
Belatacept for kidney transplant recipients.
- Published in:
- Nephrology, 2015, v. 20, n. 10, p. 752, doi. 10.1111/nep.12589
- Publication type:
- Article
No. 2023-10: Kidney Transplantation and Immunosuppressive Agents.
- Published in:
- International Journal of Organ Transplantation Medicine, 2023, v. 14, n. 4, p. 82
- By:
- Publication type:
- Article
A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.
- Published in:
- PLoS ONE, 2019, v. 14, n. 7, p. 1, doi. 10.1371/journal.pone.0218709
- By:
- Publication type:
- Article
Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216300
- By:
- Publication type:
- Article
Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0214256
- By:
- Publication type:
- Article
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 6, p. 2437, doi. 10.3390/jcm12062437
- By:
- Publication type:
- Article
Assessment of Renal Transplant Perfusion by Contrast-Enhanced Ultrasound after Switch from Calcineurin Inhibitor to Belatacept: A Pilot Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4354, doi. 10.3390/jcm11154354
- By:
- Publication type:
- Article
Time-Limited Therapy with Belatacept in Kidney Transplant Recipients.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 11, p. 3229, doi. 10.3390/jcm11113229
- By:
- Publication type:
- Article
Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 21, p. 5159, doi. 10.3390/jcm10215159
- By:
- Publication type:
- Article
Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3479, doi. 10.3390/jcm9113479
- By:
- Publication type:
- Article
Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk—A Single Center Experience.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 8, p. 1164, doi. 10.3390/jcm8081164
- By:
- Publication type:
- Article
A Validated LC-MS/MS Method for Performing Belatacept Drug Monitoring in Renal Transplantation.
- Published in:
- Biomedicines, 2023, v. 11, n. 11, p. 2955, doi. 10.3390/biomedicines11112955
- By:
- Publication type:
- Article
Extracellular vesicle‐bound DNA in urine is indicative of kidney allograft injury.
- Published in:
- Journal of Extracellular Vesicles, 2022, v. 11, n. 9, p. 1, doi. 10.1002/jev2.12268
- By:
- Publication type:
- Article
Commentary: Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01615
- By:
- Publication type:
- Article
Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study.
- Published in:
- Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.13544
- By:
- Publication type:
- Article
Belatacept Rescue Therapy in the Early Period After Simultaneous Kidney-Pancreas Transplantation.
- Published in:
- Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.12628
- By:
- Publication type:
- Article
Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series.
- Published in:
- Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.12778
- By:
- Publication type:
- Article
Formulation and evaluation of topical Calcineurin inhibitor loaded transfersomal drug delivery for Vitiligo.
- Published in:
- Journal of Drug Delivery & Therapeutics, 2019, v. 9, p. 88, doi. 10.22270/jddt.v9i2-s.2467
- By:
- Publication type:
- Article
Explaining the "Unexpectedly High" Frequency of Invasive Fungal Disease in a Cohort Study of Solid Organ Transplant Recipients Treated With Belatacept.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae291
- By:
- Publication type:
- Article
An Unexpectedly High Incidence of Invasive Fungal Diseases in Solid Organ Transplant Recipients Taking Belatacept for Organ Rejection Prophylaxis: A Single-Center Retrospective Cohort Study.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae158
- By:
- Publication type:
- Article
Preventive CTLA-4-Ig Treatment Reduces Hepatic Egg Load and Hepatic Fibrosis in Schistosoma mansoni-Infected Mice.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/1704238
- By:
- Publication type:
- Article
Comment on "Belatacept‐based immunosuppression does not confer an increased risk of BK polyomavirus‐DNAemia relative to tacrolimus‐based immunosuppression".
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 5, p. 1, doi. 10.1111/tid.14360
- By:
- Publication type:
- Article
Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation.
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 5, p. 1, doi. 10.1111/tid.14318
- By:
- Publication type:
- Article
Belatacept‐based immunosuppression does not confer increased risk of BK polyomavirus‐DNAemia relative to tacrolimus‐based immunosuppression.
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 5, p. 1, doi. 10.1111/tid.14298
- By:
- Publication type:
- Article
Clinical outcomes of SARS‐CoV‐2 infection in kidney transplant recipients on belatacept: a single‐center experience.
- Published in:
- Transplant Infectious Disease, 2024, v. 26, n. 2, p. 1, doi. 10.1111/tid.14253
- By:
- Publication type:
- Article
Tuberculosis treatment without rifampin in kidney/kidney–pancreas transplantation: A case series report.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 6, p. 1, doi. 10.1111/tid.13949
- By:
- Publication type:
- Article
Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 6, p. 1, doi. 10.1111/tid.13983
- By:
- Publication type:
- Article
Belatacept may result in profound and persistent loss of cytomegalovirus‐specific cell‐mediated immunity: A case report.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 2, p. 1, doi. 10.1111/tid.13795
- By:
- Publication type:
- Article
Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 5, p. n/a, doi. 10.1111/tid.12748
- By:
- Publication type:
- Article
Fatal case of cutaneous-sparing orolaryngeal zoster in a renal transplant recipient.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 4, p. n/a, doi. 10.1111/tid.12704
- By:
- Publication type:
- Article
Belatacept inhibit human B cell germinal center development in immunodeficient mice.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40700-w
- By:
- Publication type:
- Article
Belatacept for Kidney Transplant Patients- Addition to the Immunosuppressive Task Force.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Costimulation blockade and Tregs in solid organ transplantation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.969633
- By:
- Publication type:
- Article
Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.918887
- By:
- Publication type:
- Article
Indirect treatment comparison of belatacept versus tacrolimus from a systematic review of immunosuppressive therapies for kidney transplant patients.
- Published in:
- Current Medical Research & Opinion, 2016, v. 32, n. 6, p. 1065, doi. 10.1185/03007995.2016.1157463
- By:
- Publication type:
- Article
A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients.
- Published in:
- Current Medical Research & Opinion, 2014, v. 30, n. 8, p. 1473, doi. 10.1185/03007995.2014.898140
- By:
- Publication type:
- Article
Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 9, p. 1951, doi. 10.3390/v14091951
- By:
- Publication type:
- Article
Belatacept as a Treatment Option in Patients with Severe BK Polyomavirus Infection and High Immunological Risk—Walking a Tightrope between Viral Control and Prevention of Rejection.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 5, p. 1005, doi. 10.3390/v14051005
- By:
- Publication type:
- Article
Patterns of belatacept use and risk of post-transplant lymphoproliferative disorder in US kidney transplant recipients: An analysis of the Organ Procurement and Transplantation Network database.
- Published in:
- PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0311935
- By:
- Publication type:
- Article
Risk of posttransplant lymphoproliferative disorder associated with use of belatacept.
- Published in:
- American Journal of Health-System Pharmacy, 2013, v. 70, n. 22, p. 1977, doi. 10.2146/ajhp120770
- By:
- Publication type:
- Article
Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.
- Published in:
- 2020
- By:
- Publication type:
- journal article
PD54 Associated Factors Renal Graft Loss Using Real-World Evidence In Brazil.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
A Calcineurin Regulator MoRCN1 Is Important for Asexual Development, Stress Response, and Plant Infection of Magnaporthe oryzae.
- Published in:
- Frontiers in Plant Science, 2022, v. 13, p. 1, doi. 10.3389/fpls.2022.925645
- By:
- Publication type:
- Article
Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2024.1491514
- By:
- Publication type:
- Article
Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1447503
- Publication type:
- Article
Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2022.918887
- By:
- Publication type:
- Article